It looks like pharmaceutical company Pfizer will pay $250 million to settle more than 10,000 lawsuits filed over a heartburn ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, ...
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
A Delaware judge has permitted over 70,000 lawsuits against former Zantac makers to proceed, allowing expert testimonies that ...
The jury in Cook County, Illinois circuit court agreed with arguments from drugmakers GSK and Boehringer Ingelheim that the ...
A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This ...
Sen. Ron Wyden questions why Pfizer's tax rate over the last few years is significantly less than the U.S. corporate tax rate ...
French drug major Sanofi (SNYNF, SNY) announced Tuesday a collaboration with Formation Bio and AI research and deployment company ...
Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer ...